Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: bleeding

DOACs and bleeding: the role of antidotes

Presented By
Dr Kaveshree Govender, Milpark Hospital, South Africa
Trial
RE-VERSE AD
Conference
EHRA 2021

16 June, 2021 10:26

Fewer adverse events with ticagrelor monotherapy after 3 months DAPT

Presented By
Prof. Y.S. Jang, Yonsei University, South Korea
Trial
TICO
Conference
ACC 2020

8 September, 2020 15:29

TWILIGHT sub-study: same outcomes for diabetes patients

Presented By
Prof. D. Angiolillo, University of Florida - Jacksonville, USA
Trial
TWILIGHT, TWILIGHT-DM
Conference
ACC 2020

8 September, 2020 15:24

LAAO Watchman registry data positive

Presented By
Prof. James V. Freeman, Yale University School of Medicine, USA
Conference
ACC 2020

8 September, 2020 15:14

TAVR versus surgery in older patients

Presented By
Dr W. Toff, University of Leicester, UK
Trial
UK TAVI
Conference
ACC 2020

8 September, 2020 13:08

Rivaroxaban and aspirin effective and safe for PAD patients

Presented By
Prof. Marc Bonaca, University of Colorado, USA
Trial
VOYAGER PAD
Conference
ACC 2020

7 September, 2020 23:19

Edoxaban: alternative to warfarin after surgical aortic or mitral valve procedures?

Presented By
Dr G.R. Hong, Yonsei University College of Medicine, South Korea
Trial
ENAVLE
Conference
ACC 2020

7 September, 2020 23:15

Apixaban offers new perspective for cancer patients in need of anticoagulation

Presented By
Prof. G. Agnelli, University of Perugia, Italy
Trial
Phase 3, CARAVAGGIO
Conference
ACC 2020

7 September, 2020 23:13

Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery

Presented By
Prof. N. Rosencher, Paris Center University Hospital, France
Trial
PRONOMOS
Conference
ACC 2020

7 September, 2020 23:07

Ticagrelor monotherapy safe after dual antiplatelet therapy

Trial
GLASSY; GLOBAL LEADERS
Conference
ACC 2019

6 June, 2019 12:34

P2Y12 inhibitor monotherapy is a novel antiplatelet strategy after short duration DAPT

Conference
ACC 2019

6 June, 2019 11:39
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy